Litigation Details for Teva Pharmaceuticals USA, Inc. v. Corcept Therapeutics, Inc. (N.D. Cal. 2024)

✉ Email this page to a colleague

Docket	⤷ Sign Up	Date Filed	2024-06-13
Court	District Court, N.D. California	Date Terminated
Cause	28:1337 Sherman-Clayton Act	Assigned To	Beth Labson Freeman
Jury Demand	Plaintiff	Referred To
Patents	10,166,242; 10,166,243; 10,195,214; 10,500,216; 8,921,348; 9,829,495; 9,943,526
Link to Docket	External link to docket

The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2024-06-13	1	Complaint	the ‘495 patent, U.S. Patent No. 9,943,526 (the ‘526 patent), U.S. Patent No. 10,166,242 (the ‘242 27 … patent), U.S. Patent No. 10,166,243 (the ‘243 patent), U.S. Patent No. 10,500,216 (the ‘216 patent),…348 patent) and U.S. patent number 9,829,495 9 (the ‘495 patent). Neither of these patents had…infringing two more patents: U.S. 13 patent number 10,842,800 (the ‘800 patent), and U.S. patent number 10,842,801… ‘348 patent at 1. 53 25 ‘348 patent col. 16 l. 25-35. The ‘348 patent also has six	External link to document
2024-09-13	39	Amended Complaint	dropping in July 2019 89; U.S. Patent No. 10,166,242 (the ‘242 patent) and U.S. 21 85 …348 patent) and U.S. patent number 9,829,495 15 (the ‘495 patent). Neither of these patents had…infringing two more patents: U.S. 21 patent number 10,842,800 (the ‘800 patent), and U.S. patent number 10,842,801… ‘348 patent at 1. 53 26 ‘348 patent col. 16 l. 25-35. The ‘348 patent also has six… 91. The ‘348 and ‘495 patents are method-of-use patents. Neither patent even purports to 10 claim	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document